Back to HomeBeta

ICD-10 Coding for B-cell Lymphoproliferative Disorder(C83.3, D47.2)

Complete ICD-10-CM coding and documentation guide for B-cell Lymphoproliferative Disorder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

B-cell LymphomaMonoclonal B-cell LymphocytosisDiffuse Large B-cell Lymphoma

Related ICD-10 Code Ranges

Complete code families applicable to B-cell Lymphoproliferative Disorder

C81-C96Primary Range

Malignant neoplasms of lymphoid, hematopoietic and related tissue

This range includes various types of lymphomas, including B-cell lymphomas.

Monoclonal gammopathy

This code is used for monoclonal B-cell lymphocytosis, a precursor condition to more severe lymphoproliferative disorders.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C83.3Diffuse large B-cell lymphomaUse when documentation specifies diffuse large B-cell lymphoma without indicating primary CNS involvement.
  • Histopathological confirmation of large B-cell morphology
  • Immunohistochemistry showing CD20 positivity
D47.2Monoclonal gammopathyUse for asymptomatic monoclonal B-cell populations with no extramedullary involvement.
  • Flow cytometry showing monoclonal B-cell population <5x10⁹/L
  • Absence of lymphadenopathy or organomegaly

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for B-cell lymphoproliferative disorder

Essential facts and insights about B-cell Lymphoproliferative Disorder

The ICD-10 code for diffuse large B-cell lymphoma is C83.3, while monoclonal B-cell lymphocytosis is coded as D47.2.

Primary ICD-10-CM Codes for brother cell lymphoproliferative disorder

Diffuse large B-cell lymphoma
Non-billable Code

Decision Criteria

documentation Criteria

  • Presence of 'primary' in CNS lymphoma documentation

Applicable To

  • Diffuse large B-cell lymphoma not specified as primary

Excludes

  • Primary central nervous system lymphoma (C83.31)

Clinical Validation Requirements

  • Histopathological confirmation of large B-cell morphology
  • Immunohistochemistry showing CD20 positivity

Code-Specific Risks

  • Misclassification if 'primary' is not specified for CNS involvement

Coding Notes

  • Ensure 'primary' is documented for CNS cases to avoid incorrect coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of non-Hodgkin lymphoma

Z85.72
Use to indicate a history of lymphoma in remission.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Primary central nervous system lymphoma

C83.31
Use when documentation specifies primary CNS involvement.

Chronic lymphocytic leukemia

C91.1
Use when B-cell count is ≥5x10⁹/L or lymphadenopathy is present.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting B-cell Lymphoproliferative Disorder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C83.3.

Impact

Clinical: May lead to incorrect diagnosis and treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to lack of specificity.

Mitigation Strategy

Ensure flow cytometry results are included in documentation.

Impact

Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Potential non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.

Mitigation Strategy

Query provider to confirm if CNS involvement is primary.

Impact

Risk of incorrect coding without 'primary' documentation.

Mitigation Strategy

Implement provider queries for clarification.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for B-cell Lymphoproliferative Disorder, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for B-cell Lymphoproliferative Disorder

Use these documentation templates to ensure complete and accurate documentation for B-cell Lymphoproliferative Disorder. These templates include all required elements for proper coding and billing.

Monitoring Monoclonal B-cell Lymphocytosis

Specialty: Hematology

Required Elements

  • Flow cytometry results
  • B-cell count
  • Absence of lymphadenopathy

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lymphocytosis noted.
Good Documentation Example
Monoclonal B-cell lymphocytosis, CD19+ CD5- κ-restricted, 2.8% of WBCs. No lymphadenopathy.
Explanation
The good example provides specific flow cytometry results and absence of lymphadenopathy, crucial for accurate coding.

Need help with ICD-10 coding for B-cell Lymphoproliferative Disorder? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more